» Authors » Philip M Sherman

Philip M Sherman

Explore the profile of Philip M Sherman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 159
Citations 4924
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pell L, Qamar H, Bassani D, Heasley C, Funk C, Chen C, et al.
mSphere . 2025 Feb; :e0103224. PMID: 39992135
Importance: Among infants born in Dhaka, Bangladesh, a 7-day regimen of ATCC 202195 (LP202195) plus fructooligosaccharide (FOS) did not colonize the infant gastrointestinal (GI) tract. The absence of colonization is...
2.
Shama S, Asbury M, Kiss A, Bando N, Butcher J, Comelli E, et al.
Cell Rep Med . 2024 Sep; 5(9):101729. PMID: 39243753
Mother's milk contains diverse bacterial communities, although their impact on microbial colonization in very-low-birth-weight (VLBW, <1,500 g) infants remains unknown. Here, we examine relationships between the microbiota in preterm mother's...
3.
Zito A, Wu R, Li B, Botts S, Feizi M, Lee D, et al.
Pediatr Surg Int . 2024 Jan; 40(1):35. PMID: 38216767
Purpose: Necrotizing enterocolitis (NEC) is a severe intestinal disease primarily affecting premature infants, marked by impaired epithelial regeneration. Breastfed infants are less susceptible to NEC than formula-fed ones, and human...
4.
Shawon J, Pell L, Kabir M, Evans K, Hasan M, Li G, et al.
Microbiol Spectr . 2023 Nov; 12(1):e0271123. PMID: 38018977
When administered for seven consecutive days shortly after birth, the probiotic bacterium ATCC 202195 plus fructooligosaccharide (FOS) was reported to reduce sepsis and lower respiratory tract infection events during early...
5.
Wang Y, Florez I, Morgan R, Foroutan F, Chang Y, Crandon H, et al.
JAMA Pediatr . 2023 Oct; 177(11):1158-1167. PMID: 37782505
Importance: Modulation of intestinal microbiome by administering probiotics, prebiotics, or both may prevent morbidity and mortality in premature infants. Objective: To assess the comparative effectiveness of alternative prophylactic strategies through...
6.
Asbury M, Shama S, Sa J, Bando N, Butcher J, Comelli E, et al.
Cell Host Microbe . 2022 Aug; 30(9):1328-1339.e5. PMID: 35987195
Nutrient fortifiers are added to human milk to support the development of very-low-birth-weight infants. Currently, bovine-milk-based fortifiers (BMBFs) are predominantly administered, with increasing interest in adopting human-milk-based fortifiers (HMBFs). Although...
7.
Horne R, Freedman S, Johnson-Henry K, Pang X, Lee B, Farion K, et al.
Front Cell Infect Microbiol . 2022 Jul; 12:883163. PMID: 35774405
Clinical Trial Registration: www.ClinicalTrials.gov, identifier: NCT01853124.
8.
Wu R, Botts S, Johnson-Henry K, Landberg E, Abrahamsson T, Sherman P
Nutrients . 2022 Mar; 14(5). PMID: 35267989
Background: Human milk oligosaccharides are complex, non-digestible carbohydrates that directly interact with intestinal epithelial cells to alter barrier function and host inflammation. Oligosaccharide composition varies widely between individual mothers, but...
9.
Wu R, Li B, Horne R, Ahmed A, Lee D, Robinson S, et al.
Mol Nutr Food Res . 2021 Dec; 66(4):e2100893. PMID: 34921749
Scope: Necrotizing enterocolitis (NEC) is a devastating gastrointestinal emergency affecting preterm infants. Breastmilk protects against NEC, partly due to human milk oligosaccharides (HMOs). HMO compositions are highly diverse, and it...
10.
Li B, Lee C, Cadete M, OConnell J, Alganabi M, Lee D, et al.
Pediatr Res . 2021 Sep; 91(1):101-106. PMID: 34561550
Background: Stem cell therapy has been proven to rescue intestinal injury and stimulate intestinal regeneration in necrotizing enterocolitis (NEC). Specifically, stem cells derived from amniotic fluid (AFSCs) and mesenchymal stem...